BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1343@pharmaconomics
DTSTAMP:20260707T040738Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:MESO Approval — rexlemestrocel-L (estimated date)
DESCRIPTION:A final FDA approval decision on rexlemestrocel-L for chronic low back pain is expected ~ Sep 30\, 2027.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1345099/000134509926000051/exhibit991clbppivotaltri.htm\n\nTrack it: https://www.pharmaconomics.com/e/1343
URL:https://www.pharmaconomics.com/e/1343
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MESO catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR